Targeted Wellness: Tirzepatide, Supporting Peptides, and the Evolving Approach to Weight Management June 19, 2025 Revolutio nizing Weight Loss with GLP-1 Medications at ATX Infusion The growing interest in GLP-1 receptor medications like Tirzepatide signals a major shift in how we approach weight loss and metabolic health
The reasons fall into a few categories: planned (surgery, pregnancy planning, severe side effects), unplanned (insurance lapse, supply shortage, cost), or strategic (youve hit your goal and want to test maintenance)
So two schools of thought on this, I am in one camp but I will acknowledge the other camp
Many patients discover that a lower maintenance dose$149/month semaglutide or $129/month Microdose GLP-1 Protocolprevents rebound while reducing monthly costs
Past and future medical bills: This includes hospital stays, emergency room visits, specialist consultations (like gastroenterologists), diagnostic tests (like endoscopies), and prescription medications
Proven weight loss, the affordable way Up to 15-20% weight loss with Wegovy and Zepbound* Affordable GLP-1s, delivered fast** Covered by top insurance plans Proven weight loss, the affordable way Up to 15-20% weight loss with Wegovy and Zepbound* Affordable GLP-1s, delivered fast** Covered by top insurance plans *In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20% respectively, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
